Repaglinide and Metformin Hydrochloride is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Lupin Pharmaceuticals, Inc.. The primary component is Metformin Hydrochloride; Repaglinide.
Product ID | 68180-491_acd637a1-d43a-40da-90aa-247fe927e05a |
NDC | 68180-491 |
Product Type | Human Prescription Drug |
Proprietary Name | Repaglinide and Metformin Hydrochloride |
Generic Name | Repaglinide And Metformin Hydrochloride |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2015-12-10 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA200624 |
Labeler Name | Lupin Pharmaceuticals, Inc. |
Substance Name | METFORMIN HYDROCHLORIDE; REPAGLINIDE |
Active Ingredient Strength | 500 mg/1; mg/1 |
Pharm Classes | Biguanide [EPC],Biguanides [CS],Glinide [EPC],Potassium Channel Antagonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2015-12-10 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA200624 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2015-12-10 |
Marketing End Date | 2017-10-31 |
Marketing Category | ANDA |
Application Number | ANDA200624 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2015-12-10 |
Marketing End Date | 2017-10-31 |
Marketing Category | ANDA |
Application Number | ANDA200624 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2015-12-10 |
Marketing End Date | 2017-10-31 |
Ingredient | Strength |
---|---|
METFORMIN HYDROCHLORIDE | 500 mg/1 |
SPL SET ID: | fdd3b379-f8e5-41bc-8b13-a1b810ba01c8 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
68180-490 | Repaglinide and Metformin Hydrochloride | Repaglinide and Metformin Hydrochloride |
68180-491 | Repaglinide and Metformin Hydrochloride | Repaglinide and Metformin Hydrochloride |